{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:32:06Z","timestamp":1787761926883,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>ABSTRACT<\/jats:title>\n                    <jats:p>\n                      Tizanidine is a centrally acting \u03b12 agonist which has been used as a premedication due to its opioid-sparing and sympatholytic properties. This systematic review assessed the safety and feasibility of oral tizanidine. After registering the protocol with PROSPERO (CRD42022368546), randomized controlled trials and non-randomized observational studies were searched in various databases. The primary outcome was intraoperative opioid use; the secondary outcomes were 24-hr opioid consumption, pain scores, time to rescue analgesia, and adverse events. The risk of bias scale was used to assess the quality of evidence. Out of 202 studies identified, five studies fulfilled the inclusion criteria. Intraoperative opioid consumption was significantly less in the tizanidine group (MD: -2.40; 95% CI: -4.22, -0.59;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.010; I\n                      <jats:sup>2<\/jats:sup>\n                      = 0 %). The 24-hr opioid consumption was comparable between both groups (MD: -42.53, 95% CI: -91.45, 6.39;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.09; I\n                      <jats:sup>2<\/jats:sup>\n                      = 99%). Time to rescue analgesia was comparable between both groups (MD: 308.22; 95% CI: -263.67, 880.11,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.29, I\n                      <jats:sup>2<\/jats:sup>\n                      = 100%). Pain scores at 6 and 12 hours were comparable (MD: -1.37; 95% CI: -3.68, 0.94;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.24; I\n                      <jats:sup>2<\/jats:sup>\n                      = 97%) and (MD: -1.76; 95% CI: -4.06, 0.53;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.13; I\n                      <jats:sup>2<\/jats:sup>\n                      = 95%); however, at 24 hours the scores were better in the tizanidine group (MD: -1.10; 95% CI: -1.50, -0.69;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001 I\n                      <jats:sup>2<\/jats:sup>\n                      = 0%). Although dry mouth was significantly more in the tizanidine group (MD: 5.35; 95% CI: 1.72, 16.62;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004; I\n                      <jats:sup>2<\/jats:sup>\n                      = 0%), postoperative nausea\/vomiting and dizziness were comparable. Tizanidine reduces intraoperative opioid consumption without significant adverse events. However, it does not provide effective opioid-sparing analgesia or reduced opioid requirement in the first 24 hours after surgery.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sja.sja_780_22","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T22:42:22Z","timestamp":1678401742000},"page":"214-222","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of oral tizanidine premedication as pre-emptive analgesia in adult patients undergoing elective surgeries- A systematic review"],"prefix":"10.4103","volume":"17","author":[{"given":"Abhijit","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manamohan","family":"Rangaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Borkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-11-20240909","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1272\/jnms.71.105","article-title":"Effect of oral tizanidine on local-anesthetic infiltration pain during epidural catheterization","volume":"71","author":"Imanaga","year":"2004","journal-title":"J Nippon Med Sch"},{"key":"R3-11-20240909","first-page":"393","article-title":"Oral tizanidine, an alpha2-adrenoceptor agonist, reduces the minimum alveolar concentration of sevoflurane in human adults","volume":"95","author":"Wajima","year":"2002","journal-title":"Anesth Analg"},{"key":"R4-11-20240909","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5812\/ircmj.11540","article-title":"Evaluation of oral tiazinidine effects on [intraoperative] hemodynamic responses during direct laryngoscopy under general anesthesia","volume":"15","author":"Tabari","year":"2013","journal-title":"Iran Red Crescent Med J"},{"key":"R5-11-20240909","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1742-1241.2004.00454.x","article-title":"Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain","volume":"59","author":"Ketenci","year":"2005","journal-title":"Int J Clin Pract"},{"key":"R6-11-20240909","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.annemergmed.2019.02.017","article-title":"A randomized, placebo-controlled trial of ibuprofen plus metaxalone, tizanidine, or baclofen for acute low back pain","volume":"74","author":"Friedman","year":"2019","journal-title":"Ann Emerg Med"},{"key":"R7-11-20240909","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1007\/s00586-009-1019-4","article-title":"Aceclofenac-tizanidine in the treatment of acute low back pain: A double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone","volume":"18","author":"Pareek","year":"2009","journal-title":"Eur Spine J"},{"key":"R8-11-20240909","first-page":"143","article-title":"Eperisone versus tizanidine for treatment of chronic low back pain","volume":"103","author":"Rossi","year":"2012","journal-title":"Minerva Med"},{"key":"R9-11-20240909","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/2277-9175.175905","article-title":"The effect of oral tizanidine on postoperative pain relief after elective laparoscopic cholecystectomy","volume":"5","author":"Talakoub","year":"2016","journal-title":"Adv Biomed Res"},{"key":"R10-11-20240909","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/EJA.0000000000000371","article-title":"Tizanidine for the management of acute postoperative pain after inguinal hernia repair: A placebo-controlled double-blind trial","volume":"33","author":"Yazicio\u011flu","year":"2016","journal-title":"Eur J Anaesthesiol"},{"key":"R11-11-20240909","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00540-018-2468-x","article-title":"Ultrasound-guided bilateral superficial cervical block and preemptive single-dose oral tizanidine for post-thyroidectomy pain: A randomized-controlled double-blind study","volume":"32","author":"Ahiskalioglu","year":"2018","journal-title":"J Anesth"},{"key":"R12-11-20240909","doi-asserted-by":"crossref","first-page":"37","DOI":"10.52547\/wjps.11.2.37","article-title":"Is preemptive oral tizanidine effective on postoperative pain intensity after bimaxillary orthognathic surgery? A triple-blind randomized clinical trial","volume":"11","author":"Dadmehr","year":"2022","journal-title":"World J Plast Surg"},{"key":"R14-11-20240909","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R15-11-20240909","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R18-11-20240909","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/00000539-200111000-00057","article-title":"Systemic tizanidine hydrochloride (Zanaflex) relieves thermal hyperalgesia in rats with an experimental mononeuropathy","volume":"93","author":"Hord","year":"2001","journal-title":"Anesth Analg"},{"key":"R19-11-20240909","first-page":"816","article-title":"[Effects of oral alpha 2 adrenergic agonists, clonidine and tizanidine, on tetracaine spinal anesthesia]","volume":"44","author":"Omote","year":"1995","journal-title":"Masui"},{"key":"R20-11-20240909","first-page":"817","article-title":"The sedative and sympatholytic effects of oral tizanidine in healthy volunteers","volume":"82","author":"Miettinen","year":"1996","journal-title":"Anesth Analg"},{"key":"R21-11-20240909","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1248\/yakushi.12-00222","article-title":"[Clinical survey of tizanidine-induced adverse effects--impact of concomitant drugs providing cytochrome P450 1A2 modification--]","volume":"133","author":"Momo","year":"2013","journal-title":"Yakugaku Zasshi"},{"key":"R23-11-20240909","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003495-199753030-00007","article-title":"Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders","volume":"53","author":"Wagstaff","year":"1997","journal-title":"Drugs"},{"key":"R24-11-20240909","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1177\/0300060518765009","article-title":"Irreversible profound symptomatic bradycardia requiring pacemaker after tizanidine\/loxoprofen combination therapy: A case report","volume":"46","author":"Li","year":"2018","journal-title":"J Int Med Res"},{"key":"R25-11-20240909","first-page":"643","article-title":"Liver, renal, and cardiovascular failure after unintentional overdose of tizanidine in a 2-year-old child","volume":"26","author":"Vila","year":"2021","journal-title":"J Pediatr Pharmacol Ther"}],"container-title":["Saudi Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sja.sja_780_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:08:28Z","timestamp":1787760508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sja.sja_780_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/sja.sja_780_22","relation":{},"ISSN":["1658-354X"],"issn-type":[{"value":"1658-354X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}